Invenomic Capital Management’s MasTec MTZ Stock Holding History

Invenomic Capital Management’s Portfolio MTZ Stock Details MTZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-29,310	Closed	-$1.24M	–	164
2020 Q3	$1.24M	Buy	29,310 +22,789	+349%	+$980K	0.68%	51
2020 Q2	$292K	Buy	+6,521	New	+$247K	0.22%	116

Other funds holding MTZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Invenomic Capital Management's MTZ Position: Q4 2020 in Review

Invenomic Capital Management sold out of MasTec (MTZ) in Q4 2020, closing a stake of 29,310 shares — an estimated $1.24M sold.

Invenomic Capital Management first reported a position in MTZ in Q2 2020 and held it in 2 quarters. The position peaked at $1.24M in Q3 2020. 353 funds tracked by Wall St. Rank hold MTZ as of Q4 2020.

Invenomic Capital Management reported no remaining MasTec position as of Q4 2020 after selling out during the quarter.
Invenomic Capital Management sold 29,310 MasTec shares in Q4 2020, an estimated $1.24M.
Invenomic Capital Management first reported a position in MasTec in Q2 2020 and held it in 2 quarters.
Invenomic Capital Management's MasTec position peaked at $1.24M in Q3 2020.
353 funds tracked by Wall St. Rank held MasTec as of Q4 2020.

Based on Invenomic Capital Management's 13F filing for Q4 2020, filed 17 Feb 2021.